$WAT News

HSBC Maintains Buy on Waters, Raises Price Target to $435

Waters Announces FDA 510(k) Clearance of BD BACTEC FXI Culture System, Enabling Broader Access to Bloodstream Infection Diagnostics

B of A Securities Maintains Neutral on Waters, Raises Price Target to $400

Wolfe Research Assumes Waters at Outperform, Announces Price Target of $425

Waters Introduces Unrivaled Sensitivity and Speed to Benchtop HRMS with Xevo MRT P10 MS, Accelerating Multiomics Research

Waters Unveils Cyclic IMS P20 MS: The New Benchmark in Structural and Spatial Omics

Waters Unveils Cyclic IMS P20 MS: The New Benchmark in Structural and Spatial Omics

Waters Introduces Unrivaled Sensitivity and Speed to Benchtop HRMS with Xevo MRT P10 MS, Accelerating Multiomics Research

Are Wall Street Analysts Bullish on Waters Corporation Stock?

Waters Corporation: Performing Better Than Expected

Waters' (NYSE:WAT) Anemic Earnings Might Be Worse Than You Think

Waters Corporation to Present at the Jefferies Global Healthcare Conference

The 5 Most Interesting Analyst Questions From Waters Corporation’s Q1 Earnings Call

Understanding Waters (WAT) Reliance on International Revenue

Wells Fargo Maintains Equal-Weight on Waters, Raises Price Target to $370

Waters Merger With BD Recasts Growth Profile And Integration Test For Investors

Is Waters Corporation (WAT) A Good Stock To Buy Now?

What Makes Waters Corporation (WAT) an Investment Bet?

Jim Cramer Highlights Acquisition By Waters Corporation Following Quarterly Results

Waters Corporation 2026 Q1 - Results - Earnings Call Presentation